IRON Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
65.1M
-6.4%
69.5M
+3.8%
67.0M
-1.1%
67.7M
+10.2%
61.4M
R&D
46.9M
+2.2%
45.9M
-0.7%
46.2M
-8.2%
50.3M
+8.7%
46.3M
SG&A
18.1M
-23.2%
23.6M
+13.9%
20.7M
+19.5%
17.4M
+15.0%
15.1M
Operating Income
-65075000
+6.4%
-69524000
-3.8%
-66970000
+1.1%
-67696000
-10.2%
-61410000
EBITDA
-64985000
+6.4%
-69435000
-3.8%
-66881000
+1.1%
-67609000
-10.2%
-61325000
Net Income
-59532000
+6.3%
-63504000
-4.9%
-60531000
+2.9%
-62321000
-12.8%
-55247000
EPS (Basic)
$-1.54
+6.7%
$-1.65
-2.5%
$-1.61
+9.0%
$-1.77
-12.0%
$-1.58
EPS (Diluted)
$-1.54
+6.7%
$-1.65
-2.5%
$-1.61
+9.0%
$-1.77
-12.0%
$-1.58
Shares (Diluted)
38.7M
+0.5%
38.5M
+2.2%
37.7M
+7.0%
35.2M
+0.4%
35.0M
Disc Medicine (IRON) โ€” Financials